Abstract:G protein-coupled receptors (GPCRs) play important roles in a variety of biological and pathological processes. They are considered among the most desirable targets for drug development. Recent studies have demonstrated that many GPCRs, such as endothelin receptors, chemokine receptors and lysophosphatidic acid receptors have been implicated in the tumorigenesis and metastasis of multiple human cancers. In this study, we conducted an in silico analysis of GPCR gene expression in primary human tumors by analyzing some publicly available gene expression profiling data. Statistical analysis was performed on eight microarray data sets of non-small cell lung cancer, breast cancer, prostate cancer, melanoma, gastric cancer and diffused large B cell lymphoma to identify GPCRs that are up-regulated in primary or metastatic cancer cells. Our analysis has demonstrated overexpression of several GPCRs in primary tumor cells, including chemokine receptors and protease-activated receptors that were shown to be important for tumorigenesis by previous studies. In addition, we have uncovered several GPCRs, such as neuropeptide receptors, adenosine A2B receptor, P2Y purinoceptor, calcium-sensing receptor and metabotropic glutamate receptors, that are expressed at a significantly higher level in some cancer tissue and may play a role in cancer progression. Analysis of cancer samples in different disease stages also suggests that some GPCRs, such as endothelin receptor A, may be involved in early tumor progression and others, such as CXCR4, may play a critical role in tumor invasion and metastasis. The present study demonstrates the value of publicly available microarray data as a resource to gain more understanding of cancer biology, to validate previous findings from in vitro experiments, and to identify potential novel anticancer targets and biomarkers.

G protein-coupled receptor-mediated signaling of immunomodulation in tumor progression

Cancer Immunotherapies Targeting Tumor-Associated Regulatory T Cells

Targeting G Protein–Coupled Receptors in Immuno-Oncological Therapies

A Novel Classifier Combining G Protein-Coupled Receptors and the Tumor Microenvironment is Associated with Survival Status in Glioblastoma.

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

Overexpression of G Protein-Coupled Receptors in Cancer Cells: Involvement in Tumor Progression.

An Insight into GPCR and G-Proteins as Cancer Drivers

GPCRs: emerging targets for novel T cell immune checkpoint therapy

An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis

Tumor Immune Checkpoints and Their Associated Inhibitors

gC1qR: A New Target for Cancer Immunotherapy

Recent Advances of Small Molecular Regulators Targeting G Protein- Coupled Receptors Family for Oncology Immunotherapy.

The power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer therapy

The Advancement of Pathway on G Protein-coupled Receptors(GPCRs) Target to Cancer

GPRC5A: an Emerging Biomarker in Human Cancer

G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers

Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs

Dissection of Aberrant GPCR Signaling in Tumorigenesis--a Systems Biology Approach.

The Role of Chemoattractant Receptors in Shaping the Tumor Microenvironment

Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy

Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application